Acomplia (Rimonabant)
Synonyms: Slimona
Diet pill Rimonobant is a miraculous multifunctional pill that helps you short out obesity as well as smoking. Rimonobant diet pills work on the Endocannabinoid system, which controls appetite and energy expenditure (as well as the urge to smoke). This wonder pill selectively blocks some receptors in the Endocannabinoid system, thus creating a better balance which in turn suppresses appetite and the longing to overeat.
Buy now and get +20% bonus pills on your next order!
Free prescription
Our doctor prescribes online for free, and there is no doctor’s consultation fee.
Save on Shipping
We provide FREE standard shipping on all orders over $149
Discrete packaging
All orders arrive in discrete unmarked parcels. We leave the shipment description blank.
Buy Rimonobant
| Generic Acomplia (Rimonobant) 20 mg |
|---|
Rimonobant description
Brand name: Acomplia
Generic name: Rimonobant
What is Rimonobant?
- Rimonobant is the initial in a new class of therapeutic agents called Cannabinoid-1 Receptor Blockers (CB1).
- Rimonobant is used countenance within the treatment of obesity and related conditions.
How does Rimonobant work?
- Rimonobant acts by selectively blocking CB1 receptors found resource within the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle1.
- Rimonobant switches off the same brain circuits that make individuals hungry when they smoke cannabis.
- CB1 receptor bulwark with Rimonobant acts to decrease the overactivity of the endocannabinoid system (EC system)2,3. The EC system is a recently characterised physiological system that includes receptors as an example the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.
What is Rimonobant new for?
- Rimonobant is new complementary to diet and exercise to treat obese or overweight patients who suffer from kind 2 diabetes and freak levels of fat countenance within the blood.
- Sanofi argues that Rimonobant can also prevent the risk of cardiovascular disease.
- Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the drug.
Does Rimonobant also aid smoking cessation?
- Rimonobant has been studied by sanofi-aventis as an aid to smoking cessation based on studies for up to one year in over 6,500 smokers motivated to quit smoking.
- Sanofi-aventis submitted a new Drug Application to the FDA, which in turn issued a non approvable letter for Rimonobant for use in smoking cessation. An approvable letter was however issued for Rimonobant for use in weight management.
- Rimonobant has just been approved aspect element within the European Union. Is Rimonobant approved aspect element within the United States?
- No. Sanofi is still awaiting U.S. marketing go-ahead which it has said would come by the end of this year.
- U.S. health authorities have asked Sanofi for more information on Rimonobant.
- Rimonobant received European Union marketing approval in June 2006.
- The first initiate will take place in Britain in July and be followed by launches in Denmark, Ireland, Germany, Finland and Norway element within the second half of this year, according to Sanofi.
What were the results of Rimonobant Clinical trial studies?
- In clinical studies, Rimonobant has been shown to improve a wide array of cardiometabolic risk factors as well as promoting sustained weight loss4,5.
- Approximately half of the observed improvement in HDL-cholesterol, triglycerides and HbA1C (an indicator of blood sugar control) in patients who received Rimonobant 20 mg was beyond that expected from weight loss alone6.
What are the side-effects of Rimonobant?
- Side effects highlight within the trial on Rimonobant in obesity were vomiting and nausea, forcing about 19 percent of patients to leave the trial versus 13 percent of those who took placebo.
